Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial.

Hamaguchi M, Hashimoto Y, Tanaka T, Hasegawa G, Ishii M, Okada H, Mitsuhashi K, Kitagawa N, Ushigome E, Yamazaki M, Fukui M.

Open source

DOI: 10.1177/11795514211040539
Published: 2021-09-27
Container: Clin Med Insights Endocrinol Diabetes
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1177/11795514211040539,
  title = {Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial.},
  author = {Hamaguchi M and  Hashimoto Y and  Tanaka T and  Hasegawa G and  Ishii M and  Okada H and  Mitsuhashi K and  Kitagawa N and  Ushigome E and  Yamazaki M and  Fukui M.},
  year = {2021},
  journal = {Clin Med Insights Endocrinol Diabetes},
  doi = {10.1177/11795514211040539},
  url = {https://doi.org/10.1177/11795514211040539}
}

RIS

TY  - JOUR
TI  - Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial.
AU  - Hamaguchi M
AU  -  Hashimoto Y
AU  -  Tanaka T
AU  -  Hasegawa G
AU  -  Ishii M
AU  -  Okada H
AU  -  Mitsuhashi K
AU  -  Kitagawa N
AU  -  Ushigome E
AU  -  Yamazaki M
AU  -  Fukui M.
PY  - 2021
JO  - Clin Med Insights Endocrinol Diabetes
DO  - 10.1177/11795514211040539
UR  - https://doi.org/10.1177/11795514211040539
ER  -

APA

M, H., Y, H., T, T., G, H., M, I., H, O., K, M., N, K., E, U., M, Y., & M., F. (2021). Multicenter, Open-Label, 2-Arm, Pilot Trial for Safe Reduction of Basal Insulin Dose Combined with SGLT2 Inhibitor in Type 1 Diabetes Mellitus: Study Protocol for a RISING-STAR Trial.. Clin Med Insights Endocrinol Diabetes. https://doi.org/10.1177/11795514211040539

Source records

europe-pmc · retrieved 2026-09-27T15:25:33.047Z
doaj · retrieved 2026-09-27T15:25:33.023Z